A synthesis of pyridine-2(1H)-thione derivative 2 and thieno-[2,3-b] -pyridine derivatives 4,5 utilizing cyanothioacetamide and arylhydrazone of benzoylacetone 1 as starting compounds is described. Pyridinethione derivative 6 reacted with aromatic aldehyde to give styrylpyridinethione derivative 7. Compound 7 was reacted with chloroacetone to obtain thienopyridine derivative 8. Cycloaddition reaction was carried out on 8 with dienophiles, to afford the corresponding cycloadduct 9. Pyridinethione derivative 6 reacted with halogen-containing materials to give the corresponding thienopyridine derivatives 10, 17. the reaction of 10 with triethyl orthoformate or formic acid led to the formation of pyridothienopyrimdine derivative 11. The hydrazino derivative 13, gave with triethyl orthoformate triazolo-pyrimidothienopyridine derivative 14. Compound 10 reacted with nitrous acid to gave pyridothienotrizinone derivative 15. Thienopyridine derivative 17 reacted with triethyl orthoformate to give 18. Triazipinopyrimidothienopyridine derivative 20 obtained from compound 18 after reaction with hydrazine hydrate and acetylacetone. Compound 17 reacted with carbon disulfide to give pyrimidinedithione derivative 21.
Introduction
In recent years several papers dealing with the mechanism by which anticancer drugs exert their action at the molecular level have aroused considerable interest. Many different targets have been identified and characterized, including DNA and enzymes involved in processing nucleic acids, such as topoisomerases [1] [2] [3] . Intercalation of planer aromatic or heteroaromatic compounds with DNA is one of the important modes of actions in DNA drug interaction [4, 5] , based on the ability of the chromophore to bind strongly between the base pairs. In this field, the promising antitumor properties shown by ellipticine [6, 7] , as part of a program designed to investigate the biological activity of tricyclic and tetracyclic systems containing a thiophene ring as central nucleus [8, 9] .
Results and Discussion
In the present paper we reported reactions of cyanothioacetamide with arylhydrazone of benzoyl acetone 1 and benzoylacetone for the syntheis of substituted pyridine-2(1H)-thione and their condensed derivatives. Thus, it has been found that benzoylacetone coupled with aryldiazonium chloride in ethanol containing sodium acetate [10] to afford the corresponding monoarylhydrazone derivative 1 in good yield. Compound 1 reacts with cyanothioacetamide in refluxing ethanol sodium ethoxide for 5h to give the 3-cyanopyridine 2(1H)-thione derivative 2. Compound 2 reacted with ethyl iodide in DMF-sodium hydroxide to afford the corresponding S-ethyl derivative 3. The 1 H-NMR of 3 a revealed to a triplet at  1.40 ppm and a quartet at  4.53 ppm assignable to S-ethyl group of compound 3. Further confirmation of the structure 3 was given via their cyclization using sodium ethoxide solution to afford thieno [2,3-b] pyridine derivative 4. The IR spectrum of 4 showed no band of CN group and instead the band of newly NH 2 group was detected. The 1 H-NMR spectrum of 4 also revealed no signals of -SCH 2 -protons but revealed signals at  5.27 ppm for NH 2 protons. Considering the previous results, we can conclude that both-SCH 2 -and CN group in 3 may involved in the cyclization step to afford 4. When 2 was treated with phencyl bromide in ethanol-sodium ethoxide, S-alkylated derivative could not be isolated, but their cyclizations product, thieno [2,3-b] pyridine derivative 5 was obtained. The IR spectrum of 5 revealed the absence of a CN band and 1 H-NMR spectrum showed besides the aromatic proton signals at  7.21-7.98 ppm, abroad band at  4.38 ppm assignable to an amino function.
3-Cyano-6-phenyl-2-(1H)-pyridinethione 6 as starting material was prepared via condensing benzoylacetone with cyanothioacetamide [11] , and used as starting material, therefore, interaction of 6 with 2-furaldehyde afforded 3-cyano-6-phenyl-4-styryl-2(1H)-pyridinethione 7, which was converted into 2-acetyl-3-amino-6-phenyl-4-styrylthieno[2,3-b]-pyridine 8 via reaction of 7 with chloroacetone in dimethyl formamide in presence of anhydrous potassium carbonate. IR spectrum of 8 showed disappearance of (CN) band and presence of bands at 3390, 3330 cm 1 (NH 2 ). The dienic nature of 8 was investigated through their reaction with Nphenylmaleimide as dienophiles. Thus, 8 reacted with N-phenylmaleimide in ethanol [12] to afford cycloadducts 9, which could be formulated as the pyrrolo [3,4-f] quinolino[2,3:6',7'] thiophene derivative. The IR spectrum showed the two widely separated band of -CO-N-(Ph) -CO-grouping at 1750 and 1700 cm refluxing the pyrimidinone 11 in phosphorous oxychloride. The chlorine atom in 12 underwent displacement reaction when reacted with hydrazine hydrate to afford 4-hydrazino-9-methyl-7-phenylpyrido [3',2':4,5] thino [2,3- (Fig. IV) . Based on the elemental analysis and spectral data, the latter isolated product was identified as 5,7,13-trimethyl-11-phenyltriazipino 
Experimental
Melting points were taken on Gallen Kamp Melting apparatus and are uncorrected. Infrared spectra were obtained on Nexus 470-670, 1 H-NMR spectra and 13 C-NMR run on JEOL-400 MHZ in DMSO-d 6 . The mass spectra were recorded on Ms-S988 operating at 70eV. Microanalysis were performed by using pekin-Elmer 2400 CHN analyzer. The newly synthesized compounds were screened in vitro antitumor activity at Cairo University, National Cancer Institute, Cancer Biology Department, Pharmacology Unit.
Arylhydrazone of benzoylacetone (1):
A solution of benzoylacetone (2.24 g, 0.01 mol) in ethanol (100 ml) containing sodium acetate (3.0 g) was cooled to 0C, stirred and treated gradually with a cooled solution of aryldiazonium chloride (prepared from 0.01 mol of amine and appropriate quantities of HCl and NaNO 2 ). The solid product formed on standing was collected and crystallized from ethanol; m. 
3-Cyano-5-(p-chlorophenylhydrazone)-4-methyl-6-phenyl-2(1H)-pyridinethione(2).
A mixture of 1 (0.01 mol) and cyanothioacetamide (1g, 0.01 mol) was dissolved in ethanol (30 ml) containing sodium ethoxide (0.68 g, 0.01 mol). The mixture was refluxed for 5h, and then allowed to cool at room temperature and acidified with cold dilute hydrochloric acid. The resulting solid product was collected by filtration and crystallized from dioxan; m.p > 360C; yield 70%. 
2-Ethylthio-5(p-chlorophenyl hydrazone)-6-phenyl-4-methyl Pyridine-3-carbonitrile (3).
A mixture of 2 (0.01 mol), NaOH (0.4 g, 0.01 mol) and ethyl iodide (0.01 mol) in dry DMF (50 ml) was stirred at room temperature for 24h, then dilute with cold water (100 ml) and the resulting solid product was collected by filtration and 
3-Amino-5-(p-chlorophenyl hydrazone)-2,4-dimethyl-6-phenyl thieno[2,3-b] pyridine (4).
Compound 3 was heated under reflux in ethanolic sodium ethoxide solution (0.5g, 0.02 mol-atom of sodium in 25 ml of ethanol) for 1h. After cooling, the solid product was filter, wash with water and recrystallized from dioxan; m.p.> 360C; yield 60% IR (cm A mixture of 2 (0.01 mol), sodium ethoxide (0.68 g, 0.01 mol) and phencyl bromide (2.09 g, 0.01 mol) in dry ethanol (50 ml) was refluxed for 5h and then allowed to cool to room temperature and acidified with cold dilute hydrochloric acid. The resulting solid was collected by filtration and crystallized from ethanol; m.p. 150C; yield 60% IR (cm 
3-Cyano-6-phenyl-4-styryl-2-(1H)-pyridinethione (7).
To a solution of 6 (0.01 mol) in dioxan (20 ml), 2-furaldehyde (0.01 mol) and catalytic amount of piperidine were added, the reaction mixture was refluxed for 45 hr. After cooling, the precipitate was filtered and recrystallized from ethanol, m.p. 250C; yield 75%. 
2-Acetyl-3-amino-6-phenyl-4-styryl thieno[2,3-b] pyridine (8).
To a solution of 7 (0.01 mol) in dimethylformamide (50 ml), potassium carbonate anhydrous (2.76 g, 0.02 mol) and chloroacetone (0.01 mol) were added. The reaction mixture was stirred at room temperature for 7 h and then diluted with cold water (50 ml). The resulting solid product was collected by filtration , washed with water, dried and recrystallized from ethanol, m. (9) showed a molecular ion peak m/z=529 (Fig. I) 
9-Methyl-7-phenyl pyrido [3',2':4,5] thieno[3,2-d] pyrimidine-4 (3H)-one (11).

Method A:
A mixture of 10 (0.01 mol) and triethyl orthoformate (3 ml) was refluxed for 5h in ethanol in the presence of few drops of acetic acid. The solid product separated from the hot mixture was filtered and recrystallized from Dioxan, m.p. 260C, yield 85%. 
Method B
A solution of 10 (0.01 mol) and formic acid (20 ml) was heated under reflux for 4h. The solid product was collected filtrated washed with ethanol, dried then crystallized from dioxane to give 11.
4-Chloro-9-methyl-7-phenyl pyrido[3',2':4,5]thieno[3,2-d] pyrimidine (12).
A sample of the pyrimidinone derivative 11 (3g) in phosphorous oxychloride (15 ml) was refluxed for 4h, then cool. The reaction mixture was poured into ice/water mixture and the solid product was collected by filtration and recrystallized from ethanol, m.p. 165C, yield 65% IR (cm Hydrzino-9-methyl-7-phenyl-pyrido [3',2': 4,5] thieno [2,3-d] 
4-
pyrimidine (13).
A mixture of the chloro compound 12 (0.01 mol) and hydrazine hydrate (0.12 mol) in ethanol (50 ml) was refluxed for 2h. The solid product separated from the hot mixture was filtered off and recrystallized from dioxan; m.p. 320C; yield 75%. 
11-Methyl-9-phenyl-1,2,4-triazolo[4'',3'':1',6']pyrimido[4',5':4,5'] thieno[2,3-b] pyridine (14).
A mixture of 13 (0.01 mol) and triethyl orthoformate (2 ml) in ethanol (30 ml) in the presence of a few drops of acetic acid was refluxed for 5h. The solid crystals separated from the hot mixture was filtered off and recystallized from acetic acid; m.p. 280C; yield 70%. Mass spectrum showed a molecular ion peak m/z=317 (100%) (Fig. II) Anal. Calcd for C 17 H 11 N 5 S: C, 64.35; H, 3.47; N, 22.08; S,10.09. Found: C, 64.40; H, 3.50; N, 22.01; S, 10.00.
9-Methyl-7-phenylpyrido[5,4-b]thieno[3',2'-d]-(1,2,3)-triazin-4(3H)-one (15).
A cold solution of sodium nitrite (0.01 mol) was added to a cold solution of 10, ethanol (20 ml) and conc. Hydrochloric acid (0.5 ml) portionwise during period of 30 min. The reaction mixture was stirred for further 2h. in ice bath. After stirring was completed, the solid product obtained was collected by filtration, washed with water, dried, then crystallized from ethanol, m.p. 210C; yield 60%. 
3-Amino-2-cyano-4-methyl-6-phenyl-thieno [2,3-b] pyridine 17.
To a solution of 6 (0.005 mol) in ehtanolic sodium ethoxide solution in (0.5 g, 0.02-atom of sodium 25 ml of ethanol), chloroacetonitrile (0.005 mol) was added and the mixture was heated under reflux for 1h. After cooling , the solid product was collected and recrystallized from ethanol: m.p. 130C; yield 75%. 
2-Cyano-3-ethoxymethyleneamino-4-methyl-6-phenylthieno[2,3-b]pyridine (18).
A mixture of 17 (0.01 mol) and triethyl orthoformate (0.02 mol) in acetic anhydride (10 ml) was refluxed for 5h, then cool. The solid product was filtered off, washed several times with cold ethanol and recrystallized from ethanol; m.p. 170C, yield 80%. Found : C, 67.30; H, 4.60; N, 13.00; S, 9.90.
3-Amino-4-imino-9-methyl-7-phenyl pyrimido [4',5': 4,5] thieno[2,3-b] pyridine (19).
A sample of compound 18 (0.01 mol) was dissolved in dioxan (50 ml) and then hydrazine hydrate (0.01 mol) was added drop wise while stirring . Stirring was continued for 4h, during this period of time, solid crystals were separated. The mixture was heated on water bath for 1h, cool and the solid product was collected by filtration. Recrystallized from dioxan; m.p. 270C. yield 90 % IR (cm A sample of 17 (0.5 g) and carbon disulfide (3 ml) in pyridine (10 ml) was heated on water bath until the hydrogen sulfide ceased 10hr., then, cool. The solid product was filtered off, washed several times with ethanol and recrystallized from dioxan; m.p. 280C; yield 85% 
Biological Results and Structure Activity Correlation Antitumor activity (in vitro-study)
Potential cytotoxicity of the synthesized compounds was tested using the method of Skehan et al. [16] . Cells were plated in 96-muli well plate (10 cells/Well) for 24 hrs before treatment with the compound to allow attachment of cells to the wall of the plate. Different concentration of the compounds under test (0, 10, 25, 50 and 100 g/m) were added to the cell monolayer triplicate wells were prepared for each individual dose. Monolayer cells were incubated with the compounds for 48 hrs at 37C and in atmosphere of 5% CO 2 . After 48 hrs, cells were fixed, washed and stained with slufo-Rhodamine-B-stains. Excess stain was washed with acetic acid and attached stain was recovered with Tris EDTA buffer. Color intensity was measured in an ELISA reader. The relation between surviving fraction and compound drug concentration is plotted to get the survival curve of each tumor cell line after the specified compound.
The relation between surviving fraction and compound concentration was plotted to obtain the survival curve of tested cell, the response parameter calculated was IC 50 value. The data to tested compounds are summarized in Table I Compounds 6 and 7 having thiol group are nearly active as the positive control Doxorubicin [17] with IC 50 , 44.8 and 48.2 g/ml . Pyrrolo [3,4-f] quinolino [2,3:6,7] thiophene 9 is more effective than the positive control (Doxorubicin) with IC 50 8.7 g/ml. Compound 10 proved to posses moderate activity against HEPG2 cell lines. On the other hand cyclization of compound 10 yielded pyridothienotriazinone derivative 15 proved to be active toward the HEPG2 cell IC 50 52.8 g/ml. Compound 17 and 18 showed cytotoxicity to HEPG2 cells at IC 50 (98.7 and 99.3 g/ml). Compound 21 proved to be active member than the positive control (Doxorubicin) among the pyrimidine dithione molecule with IC 50 26.2 g/ml (Table  I) . concentration of compounds which cause 50% inhibition of cell growth, c positive control [17] . Compounds 6 and 9 proved to posses moderate activity against MCF7 cell line but compound 7 with increase magnitude of active at IC 50 9.4 g/ml is more effective than the positive control (Doxorubicin, due to olefinic function of the styryl pyridinethione [18] . MCF7 cell lines proved to be sensitive toward compound 10 than the positive control (Doxorubicin with IC 50 9.4 g/ml, while proveded to be moderate activity towards compounds 15, 17 and 18. Also compound 21 having thiol group is nearly as active as the positive control (Doxorubicin) with IC 50 48.3 g/ml (Table II) 
